Volrustomig Priming Regimens Exploratory Phase II Platform Study

Clinical trial NCT06448754 · RECRUITING

Trial details

NCT number: NCT06448754
Sponsor: AstraZeneca
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Non-small Cell Lung Cancer

Start date: 2024-08-27
Primary completion: 2027-07-30
Enrollment: 180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.